Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by ottawa613on Dec 01, 2016 1:38pm

68 Views

Post# 25541641

RE:NF=BS

I wouldnt hold your breath. This thing will likley sit at the .03-.055 for a very long time. Have you seen how unproffesional there website is? The hole operation came out of a mining shell company and the company markets itself more towards investors then clients. Someone is having a good christmas, shorts ftw.

GLTA

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute